Development of a physiologically based pharmacokinetic model of actinomycin D in children with cancer

AIMS: Use of the anti‐tumour antibiotic actinomycin D is associated with development of hepatotoxicity, particularly in young children. A paucity of actinomycin D pharmacokinetic data make it challenging to develop a sound rationale for defining dosing regimens in younger patients. The study aim was...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Br J Clin Pharmacol
Main Authors: Walsh, Christopher, Bonner, Jennifer J., Johnson, Trevor N., Neuhoff, Sibylle, Ghazaly, Essam A., Gribben, John G., Boddy, Alan V., Veal, Gareth J.
Format: Artigo
Jezik:Inglês
Izdano: John Wiley and Sons Inc. 2016
Teme:
Paediatric Clinical Pharmacology
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC4834588/
https://ncbi.nlm.nih.gov/pubmed/26727248
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bcp.12878
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki